Bowen's disease is in situ squamous carcinoma of the skin, mostly affecting sun-exposed areas of the body. There are many options in the treatment of Bowen's disease, with varying success rates. Five-fluorouracil (5-FU) inhibits DNA synthesis and causes death of tumor cells by targeting rapidly proliferating cells. Topical 5-FU has been used effectively in the treatment of Bowen's disease. The current report describes case of giant neglected Bowen's disease lesion in a male patient, which was successfully treated with 5-fluorouracil therapy.

A 62-year-old male patient presented at our clinic complaining of erythema and scaling. The patient had lesion that had enlarged over course of 7 years. Dermatological examination revealed infiltrative red-brown plaque with oval-round shape and well-defined and irregular margins on left lateral side of the body, measuring 13x13 cm in size with patchy crust and scaling ([Figure 1A](#F1){ref-type="fig"}). Histopathological examination of punch biopsy material demonstrated disruption of polarity in all layers of epidermis, mild-moderate atypia, multiple dyskeratotic cells, increased mitotic activity, and moderate-severe mononuclear infiltration in the upper layer of dermis. Integrity of basement membrane was preserved without invasion ([Figure 1B](#F1){ref-type="fig"}). The patient was diagnosed with Bowen's disease and treatment with topical 5-FU 5% applied twice daily was initiated. Skin ulcer developed at the site of plaque lesion 1 month after initiation of therapy, and therefore therapy was discontinued. Two months after cessation of therapy, infiltrated plaque had disappeared and lesion showed near-complete regression ([Figure 1C](#F1){ref-type="fig"}). Skin biopsy materials obtained from 3 different areas at the site of plaque lesion 1 year after therapy indicated that epidermal atypia had completely disappeared, polarity had been restored, and there was no finding in favor of Bowen's disease ([Figure 1D](#F1){ref-type="fig"}). Clinicians should not overlook effective nonsurgical treatment methods, such as topical 5-FU, in cases of Bowen's disease.
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